outperform price
eye pbm prize
nois beat rais comfort
underli cost trend note sever item
affect model season yoy comp
includ back-half weight benefit pbm
transit non-recurr retroact medicaid
payment last year launch new medicaid
under-perform medicaid state initi depress
margin expand group medicar advantag
busi meanwhil lever earn growth
acceler track ingeniorx pbm
launch next week compani alreadi see
higher-than-expect revenu effort
upsel addit servic self-insur client boost
specialti medicare-for-al polit rhetor remain
volatil factor think antm visibl well
above-averag ep growth year next
discount price-to-earnings worth real
risk time overhang resolv rais
earn estim upsid lower
price target reflect polici constraint valuat
pbm transit track begin may
revenu upsid admin fee specialti
consensu
continu drag medicaid state
invest incom lower expect
continu next page
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
cost trend
product hif lack period adjust
affect group retire busi run temporarili high increas mix higher-
trend consist management feel comfort guidanc qualiti earn
final stage prepar launch track meet financi commit
begin migrat member may
ad member minnesota januari bcb partnership
expect target margin minnesota
overal medicaid margin within target rang though state pressur
guidanc assum actuari justifi rate iowa begin juli
margin within target rang
earn dilut new group retire member drag year
continu expand margin quarter quarter
strength sell specialti product membership growth sequenti
remain path ratio risk member profit pmpm aso member profit
momentum continu rest year
 increas throughout year due pbm implement
expect earn approach full year earn higher origin
medicar busi
provid pos rebat commerci risk busi prepar
allow self-insur client choos rebat structur
day claim payabl affect chang individu busi individu claim runoff
affect yoy comparison
million except per share data
administr fee revenu
product sold
sg expens oper revenu
percentag chang share outstand dilut
net provid oper activ
goodwil intang asset
day medic claim payabl
return invest capit
return invest tangibl capit
evercor isi project april
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin april
analyst michael newshel matthew nicolai primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view research report
